These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19350656)

  • 21. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.
    Lavillette D; Morice Y; Germanidis G; Donot P; Soulier A; Pagkalos E; Sakellariou G; Intrator L; Bartosch B; Pawlotsky JM; Cosset FL
    J Virol; 2005 May; 79(10):6023-34. PubMed ID: 15857988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression.
    Wolf M; Dimitrova M; Baumert TF; Schuster C
    Nucleic Acids Res; 2008 May; 36(9):3054-64. PubMed ID: 18400784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of subgenomic HCV plasma RNA in immunosilent infections.
    Bernardin F; Stramer SL; Rehermann B; Page-Shafer K; Cooper S; Bangsberg DR; Hahn J; Tobler L; Busch M; Delwart E
    Virology; 2007 Sep; 365(2):446-56. PubMed ID: 17493654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
    Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment.
    Allander T; Medin C; Jacobson SH; Grillner L; Persson MA
    J Med Virol; 1994 Aug; 43(4):415-9. PubMed ID: 7545963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein.
    Baril M; Brakier-Gingras L
    Nucleic Acids Res; 2005; 33(5):1474-86. PubMed ID: 15755749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
    Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
    AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays.
    Lelie PN; Cuypers HT; Reesink HW; van der Poel CL; Winkel I; Bakker E; van Exel-Oehlers PJ; Vallari D; Allain JP; Mimms L
    J Med Virol; 1992 Jul; 37(3):203-9. PubMed ID: 1331309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma.
    Sakamoto N; Enomoto N; Marumo F; Sato C
    J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
    Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
    Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis.
    Katsoulidou A; Paraskevis D; Kalapothaki V; Arvanitis D; Karayiannis P; Hadjiconstantiou V; Hatzakis A
    Nephrol Dial Transplant; 1999 May; 14(5):1188-94. PubMed ID: 10344360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the hemodialysis machine?
    Delarocque-Astagneau E; Baffoy N; Thiers V; Simon N; de Valk H; Laperche S; Couroucé AM; Astagneau P; Buisson C; Desenclos JC
    Infect Control Hosp Epidemiol; 2002 Jun; 23(6):328-34. PubMed ID: 12083237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand.
    Thongsawat S; Maneekarn N; Kuniholm MH; Pantip C; Thungsuputi A; Lumlertkul D; Bannachak D; Nelson KE
    J Med Virol; 2008 May; 80(5):808-15. PubMed ID: 18360894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
    Mattsson L; Grillner L; Weiland O
    Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C Virus Frameshift/Alternate Reading Frame Protein Suppresses Interferon Responses Mediated by Pattern Recognition Receptor Retinoic-Acid-Inducible Gene-I.
    Park SB; Seronello S; Mayer W; Ojcius DM
    PLoS One; 2016; 11(7):e0158419. PubMed ID: 27404108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
    Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber PS; Marinos G; Levy MH; Kaldor JM; Dolan KA; Ffrench RA; Lloyd AR; Rawlinson WD;
    J Infect Dis; 2004 May; 189(10):1846-55. PubMed ID: 15122521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
    Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
    Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study.
    Hosseini-Moghaddam SM; Keyvani H; Kasiri H; Kazemeyni SM; Basiri A; Aghel N; Alavian SM
    J Med Virol; 2006 May; 78(5):569-73. PubMed ID: 16555284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.